- NeoStem (NBS +6.4%) jumps after saying the National Institute of Arthritis and Musculoskeletal and Skin Diseases has awarded the company nearly $148K for the "Development of Adult Pluripotent VSEL stem cells to treat skin wounds in Scleroderma."
- Depending on the results of the study (which will employ a tight skin mouse), the company may be eligible to receive an additional $1.5M in grants. (PR)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs